Tag: CanniMed Therapeutics
Aurora Cannabis Commences Compulsory Acquisition of Remaining CanniMed Shares EDMONTON, April 13, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the...
CanniMed Signs Letter of Intent with Pharmasave EDMONTON and SASKATOON, April 4, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed...
Resigning CEO Brent Zettl to Provide Advisory Services EDMONTON and SASKATOON, April 2, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and...
After a massive 17.7% decline in February, the Canadian Cannabis LP Index recovered just some of the losses in March, rallying 0.8% after having been up more than 13% earlier in...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter...
Aurora Cannabis Finalizes Largest Acquisition in Cannabis Industry History Transaction Establishes Global Medical Cannabis Leader EDMONTON, March 28, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX:...
Aurora Acquires CanniMed and Commences Integration EDMONTON, March 15, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has...
Aurora Cannabis Succeeds in Bid for CanniMed – Takes Up Shares Announces Mandatory Extension of Tender Period EDMONTON, March 9, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF)...
After a strong start to the year, with the Canadian Cannabis LP Index rising 17.7% in January, the benchmark reversed out the gains in February, declining 18.6% to leave...
Aurora Cannabis Announces Final Regulatory Approval for CanniMed Therapeutics Acquisition Intends to Take-Up as soon as Minimum Tender Condition is Met EDMONTON, Feb. 28, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”)...
Aurora Cannabis and CanniMed Therapeutics File Offer Documents for Previously Announced Friendly Acquisition Initial Deposit Period Reduced EDMONTON and SASKATOON, Feb. 6, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB:...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter....
CanniMed Therapeutics Inc. Reports Financial Results for 2017 January 29, 2018 SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the fiscal...
Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction CanniMed’s Board and Special Committee Support Aurora’s Offer of Shares and Cash January 24, 2018 EDMONTON, Alberta &...
CanniMed Therapeutics Postpones Special Shareholders’ Meeting January 18, 2018 SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX:CMED) announces it has determined to postpone the Special Shareholders’ Meeting...
CanniMed Therapeutics Inc. Launches $725 Million Lawsuit Alleging Multiple Claims of Wrongdoing Related to Aurora Hostile Bid January 12, 2018 SASKATOON, Saskatchewan — (Business Wire) — CanniMed Therapeutics Inc....
CanniMed Therapeutics Inc. Announces Strategic International Cannabis Distribution Agreement with Fagron NV Fagron to utilize its existing international distribution network to market and distribute CanniMed medicinal cannabis products to...
CanniMed Releases New Letter to Shareholders SASKATOON, Saskatchewan — (Business Wire) — January 03, 2018 CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX: CMED) releases a new letter to...
Aurora Cannabis Calls for Additional Disclosure from CanniMed on “Bizarre” Newstrike Supply Agreement EDMONTON, Jan. 3, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt:...
Health Canada has issued 84 licenses to date under Authorized Licensed Producers of Cannabis for Medical Purposes (ACMPR) and has indicated that it will ramp up to over 200 in...
EDMONTON, Dec. 29, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announces that today it purchased 450,000 common shares of CanniMed Therapeutics...
Securities Regulators Cease Trade CanniMed Shareholder Rights Plan, Determine that Aurora and Locked-up CanniMed Shareholders are not Joint Actors, Aurora Take-Over Bid is not Insider Bid, and Minimum Deposit...
Aurora Cannabis to File Dissident Circular Against Proposed CanniMed-Newstrike Combination Proposed Transaction Highly Dilutive and Wholly Inadequate for CanniMed Shareholders Aurora Appoints PI Financial as Advisor in Relation to...
Aurora Cannabis Rebuts CanniMed’s Call for Government Intervention to Block Takeover Bid Saskatchewan Government Rejects CanniMed CEO’s Plea Aurora Intends to Establish Medical Cannabis Centre of Excellence in Saskatchewan...
CanniMed Therapeutics (TSX: CMED) formally launched the proxy to acquire Newstrike Resources (TSXV: HIP) (OTC: NWKRF) and its Up Cannabis licensed producer unit. Shareholders will vote at a special...
